2025
SJR Q1
JCR Q1 · 5,1
336 matched articles
SCIE
Journal detail
Bone Marrow Transplantation
- Publisher
- Springer Nature
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
0268336914765365
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,704
- Quartile Q1
- H-Index 154
- Cites/doc 3,13
- Docs (3y) 874
- Cites (3y) 2.506
Clarivate
Web of Science · JCR · 2025
- JCR Q Q1
- JIF 5,1
- 5Y JIF 4,7
- JCI 1,08
WoS indexes
- SCIE
Subject classification
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q1 | 1,704 | 5,1 | 4,7 | 1,08 | Q1 | 154 |
| 2024 | Q1 | Q1 | 1,709 | 5,2 | 4,6 | 0,99 | Q1 | 149 |
| 2023 | Q1 | Q1 | 1,318 | 4,5 | 4,5 | 0,9 | Q2 | 149 |
| 2022 | Q1 | Q1 | 1,327 | 4,8 | 4,7 | 0,88 | Q2 | 149 |
| 2021 | Q1 | Q2 | 0,998 | 5,2 | 5,4 | 0,94 | Q1 | 149 |
| 2020 | Q1 | Q1 | 1,609 | 5,5 | 5,5 | 1,01 | Q1 | 149 |
| 2019 | Q1 | Q1 | 1,639 | 4,7 | 4,4 | 1,04 | Q1 | 149 |
| 2018 | — | Q1 | — | 4,7 | 4,6 | 0,99 | Q1 | — |
| 2017 | Q1 | Q1 | 1,935 | 4,5 | 4,4 | 1,03 | Q1 | 149 |
| 2016 | Q1 | Q2 | 1,986 | 3,9 | 4 | — | — | 149 |
| 2015 | Q1 | Q2 | 1,57 | 3,6 | 3,5 | — | — | 149 |
| 2014 | Q1 | Q2 | 1,534 | 3,6 | 3,4 | — | — | 149 |
| 2013 | Q1 | Q2 | 1,299 | 3,5 | 3,2 | — | — | 149 |
| 2012 | Q1 | Q2 | 1,468 | 3,5 | 3,4 | — | — | 149 |
| 2011 | Q1 | Q1 | 1,422 | 3,7 | 3,3 | — | — | 149 |
| 2010 | Q1 | Q1 | 1,204 | 3,7 | 3,3 | — | — | 149 |
| 2009 | — | Q2 | — | 3 | 2,7 | — | — | — |
| 2008 | — | Q2 | — | 3,4 | 2,9 | — | — | — |
| 2007 | — | Q2 | — | 3 | 2,5 | — | — | — |
| 2006 | — | Q2 | — | 2,6 | — | — | — | — |
| 2005 | — | Q2 | — | 2,6 | — | — | — | — |
| 2004 | — | Q2 | — | 2,1 | — | — | — | — |
| 2003 | — | Q2 | — | 2,2 | — | — | — | — |
| 2002 | — | Q2 | — | 2,4 | — | — | — | — |
| 2001 | — | Q1 | — | 2,6 | — | — | — | — |
| 2000 | — | Q2 | — | 2,4 | — | — | — | — |
| 1999 | — | Q2 | — | 2,3 | — | — | — | — |
| 1998 | — | Q2 | — | 2,1 | — | — | — | — |
| 1997 | — | Q2 | — | 2,2 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | HEMATOLOGY | SCIE | Q1 | Q1 | 18/103 |
| 2025 | IMMUNOLOGY | SCIE | Q2 | Q1 | 51/183 |
| 2025 | ONCOLOGY | SCIE | Q1 | Q1 | 83/333 |
| 2025 | TRANSPLANTATION | SCIE | Q1 | Q2 | 4/30 |
| 2024 | HEMATOLOGY | SCIE | Q1 | Q1 | 16/99 |
| 2024 | IMMUNOLOGY | SCIE | Q1 | Q2 | 41/183 |
| 2024 | ONCOLOGY | SCIE | Q1 | Q2 | 64/328 |
| 2024 | TRANSPLANTATION | SCIE | Q1 | Q2 | 4/31 |
| 2023 | HEMATOLOGY | SCIE | Q1 | Q2 | 21/97 |
| 2023 | IMMUNOLOGY | SCIE | Q2 | Q2 | 61/181 |
| 2023 | ONCOLOGY | SCIE | Q1 | Q2 | 78/322 |
| 2023 | TRANSPLANTATION | SCIE | Q1 | Q2 | 6/31 |
| 2022 | HEMATOLOGY | SCIE | Q2 | Q2 | 23/79 |
| 2022 | IMMUNOLOGY | SCIE | Q2 | Q2 | 71/161 |
| 2022 | ONCOLOGY | SCIE | Q2 | Q2 | 80/241 |
| 2022 | TRANSPLANTATION | SCIE | Q1 | Q2 | 6/26 |
| 2021 | HEMATOLOGY | SCIE | Q2 | Q1 | 31/78 |
| 2021 | IMMUNOLOGY | SCIE | Q2 | Q2 | 70/162 |
| 2021 | ONCOLOGY | SCIE | Q2 | Q2 | 87/245 |
| 2021 | TRANSPLANTATION | SCIE | Q2 | Q2 | 7/25 |
| 2020 | HEMATOLOGY | SCIE | Q2 | Q1 | 21/76 |
| 2020 | IMMUNOLOGY | SCIE | Q2 | Q2 | 51/162 |
| 2020 | ONCOLOGY | SCIE | Q2 | Q2 | 79/242 |
| 2020 | TRANSPLANTATION | SCIE | Q1 | Q2 | 6/25 |
| 2019 | HEMATOLOGY | SCIE | Q1 | Q1 | 16/76 |
| 2019 | IMMUNOLOGY | SCIE | Q2 | Q2 | 47/159 |
| 2019 | ONCOLOGY | SCIE | Q2 | Q1 | 71/244 |
| 2019 | TRANSPLANTATION | SCIE | Q1 | Q2 | 3/24 |
| 2018 | HEMATOLOGY | SCIE | Q1 | Q1 | 16/73 |
| 2018 | IMMUNOLOGY | SCIE | Q2 | Q2 | 46/158 |
| 2018 | ONCOLOGY | SCIE | Q2 | Q2 | 60/230 |
| 2018 | TRANSPLANTATION | SCIE | Q1 | Q2 | 4/25 |
| 2017 | HEMATOLOGY | SCIE | Q1 | Q1 | 15/71 |
| 2017 | IMMUNOLOGY | SCIE | Q2 | Q2 | 40/155 |
| 2017 | ONCOLOGY | SCIE | Q2 | Q2 | 62/223 |
| 2017 | TRANSPLANTATION | SCIE | Q1 | Q2 | 5/25 |
| 2016 | HEMATOLOGY | SCIE | Q2 | — | 20/70 |
| 2016 | IMMUNOLOGY | SCIE | Q2 | — | 48/151 |
| 2016 | ONCOLOGY | SCIE | Q2 | — | 71/217 |
| 2016 | TRANSPLANTATION | SCIE | Q2 | — | 7/25 |
| 2015 | HEMATOLOGY | SCIE | Q2 | — | 21/70 |
| 2015 | IMMUNOLOGY | SCIE | Q2 | — | 54/151 |
| 2015 | ONCOLOGY | SCIE | Q2 | — | 71/213 |
| 2015 | TRANSPLANTATION | SCIE | Q2 | — | 10/25 |
| 2014 | HEMATOLOGY | SCIE | Q2 | — | 19/68 |
| 2014 | IMMUNOLOGY | SCIE | Q2 | — | 53/148 |
| 2014 | ONCOLOGY | SCIE | Q2 | — | 71/211 |
| 2014 | TRANSPLANTATION | SCIE | Q2 | — | 8/25 |
| 2013 | HEMATOLOGY | SCIE | Q2 | — | 21/68 |
| 2013 | IMMUNOLOGY | SCIE | Q2 | — | 55/144 |
| 2013 | ONCOLOGY | SCIE | Q2 | — | 69/203 |
| 2013 | TRANSPLANTATION | SCIE | Q2 | — | 8/26 |
| 2012 | HEMATOLOGY | SCIE | Q2 | — | 21/67 |
| 2012 | IMMUNOLOGY | SCIE | Q2 | — | 47/137 |
| 2012 | ONCOLOGY | SCIE | Q2 | — | 66/197 |
| 2012 | TRANSPLANTATION | SCIE | Q2 | — | 8/26 |
| 2011 | HEMATOLOGY | SCIE | Q2 | — | 22/68 |
| 2011 | IMMUNOLOGY | SCIE | Q2 | — | 42/139 |
| 2011 | ONCOLOGY | SCIE | Q2 | — | 53/196 |
| 2011 | TRANSPLANTATION | SCIE | Q1 | — | 6/24 |
| 2010 | HEMATOLOGY | SCIE | Q2 | — | 20/66 |
| 2010 | IMMUNOLOGY | SCIE | Q2 | — | 40/134 |
| 2010 | ONCOLOGY | SCIE | Q2 | — | 57/185 |
| 2010 | TRANSPLANTATION | SCIE | Q1 | — | 5/25 |
| 2009 | HEMATOLOGY | SCIE | Q2 | — | 22/61 |
| 2009 | IMMUNOLOGY | SCIE | Q2 | — | 55/128 |
| 2009 | ONCOLOGY | SCIE | Q2 | — | 66/166 |
| 2009 | TRANSPLANTATION | SCIE | Q2 | — | 10/24 |
| 2008 | HEMATOLOGY | SCIE | Q2 | — | 21/62 |
| 2008 | IMMUNOLOGY | SCIE | Q2 | — | 40/121 |
| 2008 | ONCOLOGY | SCIE | Q2 | — | 54/143 |
| 2008 | TRANSPLANTATION | SCIE | Q2 | — | 7/21 |
| 2007 | HEMATOLOGY | SCIE | Q2 | — | 25/63 |
| 2007 | IMMUNOLOGY | SCIE | Q2 | — | 49/119 |
| 2007 | ONCOLOGY | SCIE | Q2 | — | 56/132 |
| 2007 | TRANSPLANTATION | SCIE | Q2 | — | 9/21 |
| 2006 | HEMATOLOGY | SCIE | Q2 | — | 29/61 |
| 2006 | IMMUNOLOGY | SCIE | Q2 | — | 55/117 |
| 2006 | ONCOLOGY | SCIE | Q2 | — | 56/127 |
| 2006 | TRANSPLANTATION | SCIE | Q2 | — | 9/19 |
| 2005 | HEMATOLOGY | SCIE | Q2 | — | 23/60 |
| 2005 | IMMUNOLOGY | SCIE | Q2 | — | 49/115 |
| 2005 | ONCOLOGY | SCIE | Q2 | — | 56/123 |
| 2005 | TRANSPLANTATION | SCIE | Q2 | — | 8/20 |
| 2004 | HEMATOLOGY | SCIE | Q2 | — | 28/62 |
| 2004 | IMMUNOLOGY | SCIE | Q3 | — | 56/111 |
| 2004 | ONCOLOGY | SCIE | Q3 | — | 66/123 |
| 2004 | TRANSPLANTATION | SCIE | Q3 | — | 10/19 |
| 2003 | HEMATOLOGY | SCIE | Q2 | — | 23/62 |
| 2003 | IMMUNOLOGY | SCIE | Q2 | — | 55/114 |
| 2003 | ONCOLOGY | SCIE | Q2 | — | 60/120 |
| 2003 | TRANSPLANTATION | SCIE | Q2 | — | 9/18 |
| 2002 | HEMATOLOGY | SCIE | Q2 | — | 20/61 |
| 2002 | IMMUNOLOGY | SCIE | Q2 | — | 47/119 |
| 2002 | ONCOLOGY | SCIE | Q2 | — | 45/114 |
| 2002 | TRANSPLANTATION | SCIE | Q3 | — | 9/17 |
| 2001 | HEMATOLOGY | SCIE | Q2 | — | 16/59 |
| 2001 | IMMUNOLOGY | SCIE | Q2 | — | 40/114 |
| 2001 | ONCOLOGY | SCIE | Q2 | — | 41/107 |
| 2001 | TRANSPLANTATION | SCIE | Q1 | — | 3/16 |
| 2000 | HEMATOLOGY | SCIE | Q2 | — | 20/60 |
| 2000 | IMMUNOLOGY | SCIE | Q2 | — | 40/116 |
| 2000 | ONCOLOGY | SCIE | Q2 | — | 35/103 |
| 2000 | TRANSPLANTATION | SCIE | Q2 | — | 5/16 |
| 1999 | HEMATOLOGY | SCIE | Q2 | — | 18/60 |
| 1999 | IMMUNOLOGY | SCIE | Q2 | — | 40/115 |
| 1999 | ONCOLOGY | SCIE | Q2 | — | 37/105 |
| 1999 | TRANSPLANTATION | SCIE | Q2 | — | 6/17 |
| 1998 | HEMATOLOGY | SCIE | Q2 | — | 17/59 |
| 1998 | IMMUNOLOGY | SCIE | Q2 | — | 41/120 |
| 1998 | ONCOLOGY | SCIE | Q2 | — | 35/104 |
| 1998 | TRANSPLANTATION | SCIE | Q2 | — | 4/12 |
| 1997 | HEMATOLOGY | SCIE | Q2 | — | 17/59 |
| 1997 | IMMUNOLOGY | SCIE | Q2 | — | 32/117 |
| 1997 | ONCOLOGY | SCIE | Q2 | — | 29/102 |
| 1997 | TRANSPLANTATION | SCIE | Q2 | — | 3/9 |